Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-05

Clinical Trial Update: Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating azithromycin plus chloroquine and sulfadoxine plus pyrimethamine for intermittent preventive treatment of falciparum malaria in pregnan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)
  • Chloroquine (chloroquine)
  • Sulfadoxine-pyrimethamine (sulfadoxine-pyrimethamine)

Snippet

Sponsor: Pfizer | Conditions: Intermittent Preventive Treatment In Pregnancy (IPTp) | Phase 3 | Status: TERMINATED | Results posted: 2014-09-05